Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Total Current Assets : ¥3,124 Mil (As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Zhejiang Hisoar Pharmaceutical Co Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Zhejiang Hisoar Pharmaceutical Co's total current assets for the quarter that ended in Mar. 2025 was ¥3,124 Mil.

Zhejiang Hisoar Pharmaceutical Co Total Current Assets Historical Data

The historical data trend for Zhejiang Hisoar Pharmaceutical Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisoar Pharmaceutical Co Total Current Assets Chart

Zhejiang Hisoar Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Current Assets

Get a 7-Day Free Trial

3,237.96

3,436.92

3,245.69

2,625.74

2,890.75

Zhejiang Hisoar Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Current Assets	Get a 7-Day Free Trial															2,817.13	2,839.43	2,775.23	2,890.75	3,123.54

Zhejiang Hisoar Pharmaceutical Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Zhejiang Hisoar Pharmaceutical Co's Total Current Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1562.044	+	467.094	+	799.714	+	61.899
	=	2,891

Zhejiang Hisoar Pharmaceutical Co's Total Current Assets for the quarter that ended in Mar. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1762.251	+	496.452	+	795.68	+	69.157
	=	3,124

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Zhejiang Hisoar Pharmaceutical Co (SZSE:002099) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Zhejiang Hisoar Pharmaceutical Co's Liquidation Value for the quarter that ended in Mar. 2025 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1762.251	-	2452.798	+	0.75 * 458.418	+	0.5 * 795.68
=	51

Zhejiang Hisoar Pharmaceutical Co Total Current Assets Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisoar Pharmaceutical Co's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Hisoar Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisoar Pharmaceutical Co Ltd (SZSE:002099) » Definitions » Total Current Assets

Traded in Other Exchanges

N/A

Address

No. 507 Shifu Avenue, Taizhou International Business Plaza, Block A, 8F, Taizhou, Zhejiang, CHN, 318000

Website

http://www.hisoar.com

Zhejiang Hisoar Pharmaceutical Co Ltd is a China-based company engages in the production of specialty raw materials, preparations and fine chemicals, dyes and dye intermediates. Its products include Clindamycin hydrochloride, Clindamycin phosphate, Florfenicol, Atova, Thiamphenicol, and Riglinay.

Executives

Wang Yang Chao	Director
Yang Si Wei	Directors, executives
Xu Guo Rui	Executives
Xu Hua Qing	Secretary Dong
Hong Ming	Director
Guo Min Long	Director
Li Hong Ming	Executives
Jiang Ru Dong	Securities Affairs Representative
Mao Wen Hua	Executives
Sun Yang	Director
Li Wei Jin	Director
Luo Yu Hong	Director
Pan Qing Hua	Directors, executives
Chen Zheng Hua	Supervisors
Jia Qiang	Executives, directors

Zhejiang Hisoar Pharmaceutical Co Headlines

No Headlines